# 3D Evaluation of Postoperative Edema After Third Molar Surgery

> **NCT05941130** · PHASE4 · UNKNOWN · sponsor: **Implantology Institute** · enrollment: 40 (estimated)

## Conditions studied

- Molar, Third
- Third Molar Surgery
- Soft Tissue Swelling
- Pain, Postoperative
- Quality of Life

## Interventions

- **DRUG:** Combination of corticosteroid (methylprednisolone - Medrol, 16mg Pfizer Laboratories) therapy and non-steroidal anti-inflammatory (Ibuprofen 600mg Mylan) therapy
- **DRUG:** Non-steroidal anti-inflammatory therapy (Ibuprofen 600mg Mylan)

## Key facts

- **NCT ID:** NCT05941130
- **Lead sponsor:** Implantology Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-01
- **Primary completion:** 2023-10-15
- **Final completion:** 2024-04-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05941130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05941130, "3D Evaluation of Postoperative Edema After Third Molar Surgery". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05941130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*